Teligent Share Holder Equity 2010-2021 | TLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent share holder equity from 2010 to 2021. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent share holder equity from 2010 to 2021. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$12.6B
BridgeBio Pharma (BBIO)	$5.1B
Bausch Health Cos (BHC)	$3.4B
Amphastar Pharmaceuticals (AMPH)	$2.4B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$307M
Personalis (PSNL)	$241M
Assembly Biosciences (ASMB)	$106M
Sol-Gel Technologies (SLGL)	$16M
Evoke Pharma (EVOK)	$5M